Absci to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Absci (Nasdaq: ABSI) will participate in multiple investor conferences in March 2026, including TD Cowen, Leerink Partners, Jefferies Biotech on the Beach, and KeyBanc Healthcare Forum. The company will host fireside chats and 1x1 meetings, with select webcasts available on its investor relations site.

Live and archived webcasts of the TD Cowen, Leerink, and KeyBanc fireside chats will be posted at investors.absci.com, and specific session dates and times are listed for investors.

VANCOUVER, Wash. and NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, today announced the company will be participating in the following upcoming investor conferences:

• TD Cowen 46^th Annual Health Care Conference (Boston, MA)
  Fireside chat on Monday, March 2 at 9:10 a.m. Eastern Time / 6:10 a.m. Pacific Time, and hosting 1x1 meetings

• Leerink Partners 2026 Global Healthcare Conference (Miami, FL)
  Fireside chat on Monday, March 9 at 10:00 a.m. Eastern Time / 7:00 a.m. Pacific Time, and hosting 1x1 meetings

• Jefferies 2026 Biotech on the Beach Summit (Miami, FL)
  Hosting 1x1 meetings on Tuesday, March 10

• KeyBanc Capital Markets Healthcare Forum (Virtual)
  Fireside chat on Tuesday, March 17 at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time, and hosting 1x1 meetings
  
  

Interested parties may access live and archived webcasts of the TD Cowen, Leerink, and KeyBanc fireside chat sessions on the company’s investor relations website at: investors.absci.com.

About Absci

Absci is advancing the future of drug discovery with generative design to create better biologics for patients, faster. Our Integrated Drug Creation™ platform combines cutting-edge AI models with a synthetic biology data engine, enabling the rapid design of innovative therapeutics that address challenging therapeutic targets. Absci’s approach leverages a continuous feedback loop between advanced AI algorithms and wet lab validation. Each cycle refines our data and strengthens our models, facilitating rapid innovation and enhancing the precision of our therapeutic designs. Alongside collaborations with top pharmaceutical, biotech, tech, and academic leaders, Absci is advancing its own pipeline of AI designed therapeutics including ABS-201™, a groundbreaking innovation in hair regrowth with the potential to redefine treatment possibilities for androgenetic alopecia, commonly known as male and female pattern hair-loss. ABS-201 is also being investigated as a potential “best-in-class” therapeutic for endometriosis, a condition with significant unmet medical need and market potential. Absci is headquartered in Vancouver, WA, with AI Research Labs in New York City and Serbia, and an Innovation Center in Switzerland. Learn more at www.absci.com or follow us on LinkedIn (@absci), X (@Abscibio) and YouTube.

Absci^® standard character mark, ABS-201™, and Integrated Drug Creation™ are trademarks and registered trademarks of Absci Corporation.

Investor Contact
Alex Khan
VP, Finance & Investor Relations
investors@absci.com

Media Contact
press@absci.com

FAQ

When will Absci (ABSI) present at TD Cowen 46th Annual Health Care Conference?

Absci will present on Monday, March 2, 2026 at 9:10 a.m. ET. According to the company, the session is a fireside chat and will also include hosted 1x1 investor meetings; live and archived webcast access is available on the investor site.

How can investors watch Absci's (ABSI) Leerink Partners fireside chat on March 9, 2026?

Investors can view the Leerink fireside chat via live or archived webcast on the company's investor relations site. According to the company, the Leerink session is scheduled Monday, March 9, 2026 at 10:00 a.m. ET and the webcast will be posted at investors.absci.com.

Is Absci (ABSI) hosting investor meetings at Jefferies Biotech on the Beach on March 10, 2026?

Yes. According to the company, Absci will host 1x1 investor meetings at Jefferies Biotech on the Beach on Tuesday, March 10, 2026. No public fireside chat is listed for that event; investor meetings are the primary activity noted.

What time is Absci's (ABSI) KeyBanc Healthcare Forum fireside chat on March 17, 2026?

Absci’s KeyBanc fireside chat is scheduled for Tuesday, March 17, 2026 at 1:30 p.m. ET. According to the company, the session is a fireside chat with hosted 1x1 meetings and will be available live and archived on the investor relations website.

Where can I find archived webcasts of Absci's (ABSI) March 2026 conference presentations?

Archived webcasts for TD Cowen, Leerink, and KeyBanc sessions will be posted at investors.absci.com. According to the company, live and archived videos of those fireside chats will be available on the company's investor relations site for on-demand viewing.

Which investor conferences will Absci (ABSI) attend in March 2026 and what formats are planned?

Absci will attend TD Cowen, Leerink Partners, Jefferies Biotech on the Beach, and KeyBanc in March 2026 with fireside chats and 1x1 meetings. According to the company, formats include scheduled fireside chats (three events) and hosted one-on-one investor meetings.